W
PFE icon

WealthOne’s Pfizer PFE Stock Holding History

WealthOne’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,255
Closed -$266K – 102
2023
Q2 		$266K Sell
7,255
-264
-4% -$10.3K 0.1% 88
2023
Q1 		$307K Buy
7,519
+978
+15% +$42.2K 0.12% 74
2022
Q4 		$335K Sell
6,541
-623
-9% -$29.9K 0.14% 70
2022
Q3 		$313K Buy
7,164
+230
+3% +$11.2K 0.14% 73
2022
Q2 		$364K Sell
6,934
-419
-6% -$21.4K 0.15% 74
2022
Q1 		$381K Buy
7,353
+3,825
+108% +$198K 0.13% 75
2021
Q4 		$208K Sell
3,528
-3,300
-48% -$164K 0.07% 110
2021
Q3 		$294K Sell
6,828
-90
-1% -$3.99K 0.11% 105
2021
Q2 		$271K Sell
6,918
-560
-7% -$21.8K 0.11% 103
2021
Q1 		$271K Buy
7,478
+221
+3% +$7.85K 0.12% 102
2020
Q4 		$267K Buy
7,257
+821
+13% +$30.1K 0.13% 91
2020
Q3 		$224K Sell
6,436
-29
-0.4% -$1.02K 0.13% 95
2020
Q2 		$201K Buy
+6,465
New +$220K 0.12% 94
2019
Q1 		– Sell
-2,253
Closed -$94K – 406
2018
Q4 		$94K Buy
+2,253
New +$93.5K 0.08% 129

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WealthOne's PFE Position: Q3 2023 in Review

WealthOne sold out of Pfizer (PFE) in Q3 2023, closing a stake of 7,255 shares — an estimated $266K sold.

WealthOne first reported a position in PFE in Q4 2018 and held it in 14 quarters. The position peaked at $381K in Q1 2022. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • WealthOne reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • WealthOne sold 7,255 Pfizer shares in Q3 2023, an estimated $266K.
  • WealthOne first reported a position in Pfizer in Q4 2018 and held it in 14 quarters.
  • WealthOne's Pfizer position peaked at $381K in Q1 2022.
  • 2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on WealthOne's 13F filing for Q3 2023, filed 12 Oct 2023.